1 INDICATIONS AND USAGE
XYNTHA, Antihemophilic Factor (Recombinant), is indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for:
- On-demand treatment and control of bleeding episodes
- Perioperative management
XYNTHA does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.